Skip to main content
Smart Investors Daily
West Pharmaceutical Services, Inc. logo

NYSE · WST

West Pharmaceutical Services, Inc.

Healthcare · Medical - Instruments & Supplies

$404.02

Down-$7.33 (-1.81%)

Updated Nov 20, 2026, 1:17 AM

SID Score

6.5/10

Composite research score

Smart Money

58/100

Neutral

Market cap
19.61B
P/E ratio
40.07
Dividend yield
0.26%
52-week range
$223.83 – $438.27
Volume
595.82K
Avg. volume
696.99K

Price performance · WST

WST price history

1M range · 20 trading sessions · Daily adjusted prices

Prices through Nov 18, 2026

WST closed at $404.02 after 20 trading sessions, up 2.54% for the selected period.

Last close
$404.02
Period change
+2.54%
Period low
$392.15
Period high
$417.80
Daily close
View OHLC price history
WST OHLC price history, latest 40 sessions
DateOpenHighLowCloseVolume
Nov 18, 2026$412.89$416.9599$402.8501$404.02595.82K
Nov 17, 2026$415.85$419.593$411.92$414.12494.11K
Nov 16, 2026$417.03$420.66$415.08$417.80526.16K
Nov 13, 2026$413.38$417.39$409.0038$416.42479.12K
Nov 12, 2026$411.39$415.90$406.69$411.30378.12K
Nov 11, 2026$414.19$416.09$411.86$412.86331.52K
Nov 10, 2026$410.88$415.41$408.796$412.55455.14K
Nov 9, 2026$403.07$415.395$398.14$413.09555.26K
Nov 6, 2026$389.62$402.40$386.88$399.81625.88K
Nov 5, 2026$408.54$409.81$392.12$392.48872.91K
Nov 4, 2026$416.46$416.46$405.12$408.781.05M
Nov 3, 2026$407.39$416.23$404.52$406.991.08M
Nov 2, 2026$412.89$418.50$407.14$407.881.46M
Oct 30, 2026$419.06$422.08$407.67$412.621.06M
Oct 29, 2026$420.69$438.27$415.32$416.671.87M
Oct 28, 2026$396.95$404.985$396.83$403.64773.29K
Oct 27, 2026$392.90$398.67$391.78$398.29790.69K
Oct 26, 2026$389.80$395.28$388.06$394.73649.66K
Oct 23, 2026$391.60$394.175$389.72$392.15718.05K
Oct 22, 2026$394.15$397.155$389.17$394.03679.94K

Latest WST news

The latest Smart Investors Daily articles mentioning WST.

WST research

Overview

Company profile and research snapshot.

Company profile

West Pharmaceutical Services is based in Pennsylvania and is a key supplier to firms in the pharmaceutical, biotechnology, and generic drug industries. West sells elastomer-based packaging components (including stoppers, seals, and plungers), nonglass containment solutions, and auto-injectors for injectable drugs, which include large-molecule biologics, peptides such as GLP-1 receptor agonists, and small-molecule drugs. The company reports in two segments: proprietary products (about 80% of total revenue) and contract-manufactured products (about 20% of total revenue). It generates approximately 55% of its revenue from international markets and 45% from the United States.

Visit company website

Analyst outlook

Consensus and target data currently published for this company.

Consensus
—
Average target
$335.17
Implied upside
—
Analysts
—
WST recent ratings
DateFirmRatingTarget
Oct 30, 2026TD CowenBuy—
Oct 30, 2026BarclaysOverweight—
Oct 30, 2026Evercore ISI GroupOutperform—
Oct 30, 2026CitigroupBuy—
Oct 13, 2026TD CowenBuy—
Open full forecast

News briefing

No generated briefing is available yet.

Yahoo · Nov 13, 2026

West Pharmaceutical Services (WST) Stock May Be 29% Overvalued On Cash Flow Views

West Pharmaceutical Services has been on a strong run, and the share price now puts a clear spotlight on one question: Are investors paying a level that its future cash flows can reasonably support, or has the market moved ahead of what the business is likely to generate in hard dollars over time? The stock has returned 54.7% over the past year, which puts real pressure on the cash flow outlook to justify how far the valuation has moved. The business model, built around drug delivery...

AI research layers

Interpretive context generated from the platform’s current data sources.

No results

AI research layers have not been published yet.